Lv71
5000 积分 2022-01-07 加入
Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens
10小时前
已完结
A Real World Observational Study Characterizing Patients With Advanced Prostate Cancer Treated With or Without Androgen Receptor-Pathway-Inhibitor Therapies in Alberta, Canada
2天前
已完结
ARASAFE - a randomized, phase 3 trial comparing 3-weekly Docetaxel 75 mg/m2 (in a 3-week cycle) versus 2-weekly Docetaxel 50 mg/m2 (in a 4-week cycle) in combination with Darolutamide + ADT in patients with mHSPC
1个月前
已完结
Exploring the Dynamics of Dietary Self-Monitoring Adherence Among Participants in a Digital Behavioral Weight Loss Program: Model Development Study
2个月前
已完结
Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis
7个月前
已完结
Potential pitfalls of anti-VEGF therapy of neovascular age-related macular degeneration
7个月前
已关闭
STEAP1 as a potential target for new therapies in prostate cancer
8个月前
已关闭
Disease burden of neovascular age-related macular degeneration and diabetic macular edema
9个月前
已关闭
Prevalence and Natural History of Non-metastatic Castrate Resistant Prostate Cancer: A Population-Based Analysis
10个月前
已完结
Impact of prostate‐specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen‐deprivation therapy
10个月前
已完结
皖公网安备34019202002308
